BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 2, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Jan. 19, 2021

View Archived Issues
connected-digital-health.png

Philips snags Capsule Technologies for $635M

Royal Philips NV will close on its $635 million acquisition of Capsule Technologies Inc. in the first quarter of 2021, continuing the expansion of the Dutch company's remote monitoring capabilities. Capsule's Medical Device Information Platform integrates nearly all medical devices used in hospitals with electronic health records in a vendor-neutral system. The deal has already received approval from the U.S. Federal Trade Commission and the Department of Justice. Read More
Collaboration illustration

Thermo Fisher acquires Mesa Biotech in $450M tuck-in deal

Thermo Fisher Scientific Inc. has inked a definitive agreement to acquire Mesa Biotech Inc., a privately held molecular diagnostics company with a point-of-care (POC) platform, for approximately $450 million in cash. The scientific instruments and testing giant said it will pay an additional $100 million in cash upon the completion of certain milestones. The planned acquisition will expand Thermo Fisher’s franchise of diagnostic test options with a novel platform that enables nucleic acid polymerase chain reaction (PCR) testing at the point of care. Read More
Product image

Depuy Synthes gets FDA nod for Velys for use with the Attune total knee system

Johnson & Johnson has been looking to make a big splash in robotics. Now, its Depuy Synthes unit has made progress on this front, gaining U.S. FDA clearance for the Velys robotic-assisted solution designed for use with the Attune total knee system. The solution aims to help simplify surgeons’ existing workflow around total knee replacement. Read More
US flag, Department of Health and Human Services flags

HHS farms out LDT review to private company as Hahn calls for FDA independence

The U.S. Department of Health and Human Services (HHS) has awarded a contract for validation of lab-developed tests (LDTs) for the pandemic to a private company, a move that was apparently an effort to address the resource crunch at the U.S. Read More
australia-flag-country.png

Stakeholder survey: Drug and device companies laud TGA’s pandemic response but want process improvements

PERTH, Australia – The majority of medical device and biopharma industry respondents agreed that Australia’s Therapeutic Goods Administration (TGA) responded effectively to COVID-19, but they want to see the agency improve its processes to act faster and with more clarity, according to the TGA’s annual stakeholder survey. Read More

Holiday notice

BioWorld's offices were closed in observance of Martin Luther King Jr. Day in the U.S. No issue was published Monday, Jan. 18. Read More

Appointments and advancements for Jan. 19, 2021

New hires and promotions in the med-tech industry, including: Alma, Artificial, Bioventus, CHF Solutions, Foundation Medicine, Sophia Genetics, Zimmer Biomet. Read More

Financings for Jan. 19, 2021

Med-tech firms raising money in public or private financings, including: Ace Vision Group, Ecential Robotics, Endo Tools Therapeutics, Predictive Oncology, Senseonics. Read More

In the clinic for Jan. 19, 2021

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Accuray, Anaconda Biomed, Aseptiscope, Bionano Genomics, Kurin, Neovasc, Nevro. Read More

Other news to note for Jan. 19, 2021

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alithya Group, Applied DNA Sciences, Applied Stemcell, Artms, Bardy Diagnostics, Cardialen, Cogme, Cue Health, Diaceutics, Electrocore, Guardant Health, Gns Healthcare, Hamilton Storage, Helius Medical Technologies, Hillrom, Integrated DNA Technologies, Intersect ENT, Isotopia Molecular Imaging, Mayo Clinic Laboratories, Menon Biosensors, Mindup, Neovasc, Physiq, Qiagen, Rhinostics, Sensorion, Serotiny, Twist Bioscience, Vivos. Read More

Regulatory actions for Jan. 19, 2021

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cardiovascular Systems, Cytosorbents, Depuy Synthes, Impulse Dynamics, Medibio, Occlutech, Q Core Medical, Seno Medical, Theralight, Transenterix. Read More

Regulatory front for Jan. 19, 2021

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA to hold webinar for respirator policy. Read More

BioWorld MedTech’s Oncology Extra for Jan. 19, 2021

Keeping you up to date on recent developments in oncology, including: Heating up chemotherapy-laden nanoparticles to beat cancer; Mis-spliced RNAs in tumor cells trigger antiviral response; New approach to lung cancer screening promises savings. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 31, 2025.
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • IMV-101 shows promise for B-cell malignancies

    BioWorld Science
    IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing